| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Net loss | -15,804 | -10,847 | ||
| Earnings per share, basic | -0.4 | -0.27 | ||
| Earnings per share, diluted | -0.4 | -0.27 | ||
| Weighted average number of shares outstanding, basic | 39,741,404 | 39,572,177 | ||
| Weighted average number of shares outstanding, diluted | 39,741,404 | 39,572,177 | ||
TENAX THERAPEUTICS, INC. (TENX)
TENAX THERAPEUTICS, INC. (TENX)